Diseases of the liver and pancreas


Non-neoplastic Epithelial Disorders



Yüklə 1,15 Mb.
səhifə15/19
tarix26.03.2018
ölçüsü1,15 Mb.
#33477
1   ...   11   12   13   14   15   16   17   18   19

Non-neoplastic Epithelial Disorders

  • Characterized by opaque, white, scaly, plaque-like mucosal thickenings that produce vulvar discomfort and itching (pruritus)

  • Non specific inflammatory alterations of vulva can be classified as:

  • Lichen sclerosus: a characteristic disorder manifested by subepithelial fibrosis

  • Squamous hyperplasia: characterized by epithelial hyperplasia and hyperkeratosis


Lichen sclerosus Squamous Hyperplasia


  • Fibrosis (arrow) Epithelial hyperplasia

  • Thinning of epithelial layer Dermal chronic inflammation

Vulval Tumors

  • Benign Tumors

  • Papillary Hidradenoma

  • Condyloma Acuminatum

  • Malignant Tumors

  • Carcinoma and Vulvar Intraepithelial Neoplasia(VIN)

  • Extramammary Paget’s Disease

  • Malignant Melanoma

  • Vulva contains modified apocrine sweat glands

  • Vulva may contain tissue closely resembling breast (“ectopic breast”)

  • Develops two tumors with counterparts in the breast

  • Papillary hidradenoma is identical in appearance to intraductal papillomas of the breast.

  • Paget’s disease


Hidradenoma

  • Presents as a sharply circumscribed nodule

  • Most commonly on the labia majora or interlabial folds

  • May be confused clinically with carcinoma

  • because of its tendency to ulcerate

Histologically:

  • Tubular ducts lined by a single or double layer of nonciliated columnar cells

  • Layer of flattened “myoepithelial cells” underlying the epithelium

  • Characteristic of sweat glands and sweat gland tumors


Condyloma Acuminatum

  • Benign raised or wart-like (verrucous) conditions of the vulva occur in three forms.

  • Condyloma acuminatum, a papillomavirus-induced squamous lesion also called “venereal wart.”

  • Mucosal polyps, which are benign stromal proliferations covered with squamous epithelium

  • Syphilitic condyloma latum

  • Are sexually transmitted

  • Benign tumors

  • Have a distinctly verrucous gross appearance

  • May be solitary , frequently multiple

  • Involve perineal, vulvar, and perianal regions as well as the vagina and, less commonly, the cervix

  • Lesions are identical to those found on the penis and around the anus in males

A,B. External genitalia (female)

C. Cytoplasmic Vacuolization (Koilocytosis) – Marker for cytopathic effect of viruses

D. Koilocytosis



Condyloma Acummantum (cont.)

Histologically:

  • Consist of branching, tree-like proliferation of stratified squamous epithelium supported by a fibrous stroma

  • Acanthosis, parakeratosis, hyperkeratosis, and, most specifically, nuclear atypia in the surface cells with perinuclear vacuolization (called koilocytosis) are present.

  • Condylomata are caused by the human papillomavirus, specifically types 6 and 11,20 which are associated with benign warts and replicate in the squamous epithelium.

  • Are not considered to be precancerous lesions

  • Are a marker for sexually transmitted disease



Malignant Tumors

  • Carcinoma and Vulvar Intraepithelial Neoplasia (VIN)

  • Extramammary Paget’s Disease

  • Malignant Melanoma


Carcinoma and Vulvar Intraepithelial Neoplasia (VIN)

  • Is an uncommon malignancy

  • >65% occur in women over age 60 years

  • 85% of these malignant tumors are squamous cell carcinomas

  • In terms of etiology, pathogenesis, and clinical presentation, vulvar squamous cell carcinomas may be divided into two general groups:

  • Associated with papillomavirus

  • Asssociated with vulvular dystrophies


Associated with papillomaviruses

  • Coexists with or is preceded by a defined precancerous change, called vulvar intraepithelial neoplasia (VIN)

  • Also known as carcinoma in situ or Bowen’s disease

  • VIN is characterized by

  • Nuclear atypia in the epithelial cells

  • Increased mitoses

  • Lack of surface differentiation

  • Based on the severity of atypia, VIN may be graded as

  • I (mild)

  • II (moderate)

  • III (severe)

  • Lesions usually present as white or pigmented plaques on the vulva


Associated with vulvar “dystrophies”

  • Squamous cell hyperplasia / lichen sclerosus

  • Etiology is unclear

  • Infrequently associated with papillomaviruses

Morphology

  • Begin as small areas of epithelial thickening that resemble leukoplakia

  • In the course of time, progress to create firm, indurated, exophytic tumors or ulcerated, endophytic lesions

  • Are misinterpreted as dermatitis, eczema, or leukoplakia for long periods.

  • Clinical manifestations

  • Pain, local discomfort, itching, and exudation because superficial secondary infection is common

Histologically

  • Tumors associated with human papillomavirus or VIN tend to be poorly differentiated

  • Others are usually well differentiated, with the formation of keratohyaline pearls and prickle cells

Cancer of the Vulva Squamous Cell Carcinoma of Vulva Epithelial Pearl –

Squamous Cell Carcinoma


  • Risk of metastatic spread is linked to

  • Size of tumor

  • Depth of invasion

  • Involvement of lymphatic vessels

  • Inguinal, pelvic, iliac, and periaortic lymph nodes are most commonly involved

  • Dissemination to the lungs, liver, and other internal organs

  • Lesions less than 2 cm in diameter have a 60 to 80% 5-year survival rate after treatment with one-stage vulvectomy and lymphadenectomy

  • Larger lesions with lymph node involvement yield a less than 10% 5-year survival rate.


Extramammary Paget’s Disease

  • Rare lesion of the vulva usually on the labia majora

  • Manifests as a pruritic red, crusted, sharply demarcated, map-like area

  • Diagnostic microscopic feature:

  • Presence of large, anaplastic tumor cells lying singly or in small clusters within the epidermis and its appendages

  • These cells are distinguished by a clear separation (“halo”) from the surrounding epithelial cells

  • Finely granular cytoplasm containing PAS, alcian blue, or mucicarmine-positive mucopolysaccharide.

  • Prognosis : Poor

A.Note the appearance like an eczematoid rash (fiery red background mottled with white hyperkeratotic islands)

B.Large Clear Tumor cells within squamous epithelium
Malignant Melanoma


  • Melanomas of the vulva are rare

  • Peak incidence is in the sixth or seventh decade

  • Overall survival rate is < 32%

  • Prognosis depends on depth of invasion,

  • > 60% mortality for lesions invading deeper than 1 mm

Lesion stains with S100 which helps to



differentiate it from Paget’s disease


Vagina

  • Congenital Anomalies

  • Premalignant and Malignant Neoplasms


Congenital Anomalies

  • Atresia

  • Total absence of the vagina

  • Septate, or double, vagina

  • Arises from failure of total fusion of the müllerian ducts

  • Accompanies double uterus (uterus didelphis)

  • Gartner’s duct cysts

  • Common lesions

  • Found along the lateral walls of the vagina

  • Derived from wolffian duct rests

  • Are 1- to 2-cm, fluid-filled cysts that occur submucosally



Premalignant and Malignant Neoplasms

  • Benign tumors of the vagina

  • Occur in reproductive-age women

  • Consist of skeletal muscle (rhabdomyomas)

  • Stromal (stromal polyps) tumors

  • Leiomyomas

  • Hemangiomas

  • Malignant tumors

  • Carcinoma

  • Embryonal rhabdomyosarcoma (sarcoma botryoides)

Adenocarcinoma



  • Are rare

  • Have received attention because of the increased frequency of clear cell adenocarcinomas in young women whose mothers had been treated with diethylstilbestrol (DES) during pregnancy (for a threatened abortion)

  • < 0.14% of such DES-exposed young women develop adenocarcioma

  • Tumors are usually discovered between the ages of 15 and 20

  • Composed of vacuolated, glycogen-containing cells, hence the term “clear cell”

  • Because of its insidious, invasive growth, vaginal cancer

(squamous and adenocarcinoma) is difficult to cure.

  • Early detection by careful follow-up is mandatory in DES-exposed women




  • Treatment: Surgery and irradiation




  • Clear cell Carcinoma showing vacuolated tumor cells forming glands 

Morphology

  • Most often located

  • On the anterior wall of the vagina

  • Usually in the upper third

  • Vary in size from 0.2 to 10 cm in greatest diameter.

  • A probable precursor of the tumor is vaginal adenosis

  • A condition in which glandular columnar epithelium of müllerian type either appears beneath the squamous epithelium or replaces it.

  • Adenosis presents clinically as red, granular foci contrasting with the normal pale pink, opaque vaginal mucosa.

  • Microscopically the glandular epithelium may be either

  • Mucus-secreting, resembling endocervical mucosa

  • Tuboendometrial, often containing cilia

  • Adenosis has been reported in 35 to 90% of the offspring of estrogen-treated mothers

Vaginal Adenosis

  • Red granular patches on the vaginal mucosa on the left



Embryonal Rhabdomyosarcoma

  • Also called sarcoma botryoides

  • Very uncommon vaginal tumor

  • Most frequently found in infants and in children under the age of 5

  • Consists predominantly of malignant embryonal rhabdomyoblasts

  • Is thus a type of rhabdomyosarcoma

  • Gross:

  • Tumor tends to grow as polyploid, rounded, bulky masses that sometimes fill and project out of the vagina

  • Have the appearance and consistency of grape-like clusters (hence the designation “botryoides,” grape-like)

  • Histologically:

  • Tumor cells are small and have oval nuclei, with small protrusions of cytoplasm from one end, so they resemble a tennis racket

  • Treatment: Conservative surgery + chemotherapy

Sarcoma Botyroides


Cervix

  • Inflammations

  • Acute and Chronic Cervicitis

  • Endocervical Polyps

  • Intraepithelial and Invasive Squamous Neoplasia

Chronic Cervicitis



  • Chronic inflammation, sometimes ulceration with repair, atypia or dysplasia, nabothian cysts (from endocervical glands)

  • Backache is a common symptom

Chronic Cervicitis Chronic Cervicitis

Nabothian Cysts




A.Endocervical glands blocked by inflammation or scarring.



B.Chronic inflammation underlies an area of cervical dysplasia
Cervix - Intraepithelial and Invasive Squamous Neoplasia

Risk factors for cervical cancer:

  • Early age at first intercourse

  • Multiple sexual partners

  • Male partner with multiple previous sexual partners

  • Other risk factors (are subordinate to these three influences, primarily multiple sexual partners)

  • Oral contraceptive use

  • Cigarette smoking

  • Parity

  • Family history

  • Associated genital infections

  • Lack of circumcision in the male sexual partner.

Pathogenesis

  • ~ 85% of cervical cancers

  • ~ 90% of cervical condylomata and precancerous lesions

  • Specific human papillomavirus types are associated with

  • Cervical cancer (high risk) - Types 16, 18, 31, and 33

  • Condylomata (low risk) - Types 6, 11, 42, and 44

  • Human papillomavirus is not the only factor

  • A high percentage of young women are infected with one or more human papillomavirus types during their reproductive years, and only a few develop cancer.

  • Factors influencing whether the human papillomavirus infection remains subclinical (latent), turns into a precancer, or eventually progresses to cancer:

  • Other co-carcinogens

  • Immune status of the individual

  • Nutrition

  • ~15% of cervical cancers are not associated with human papillomavirus, implying other modes of cancer development, including host gene mutations

Postulated Steps In Pathogenesis

Cervical Intraepithelial Neoplasia

  • Pre-cancerous lesion:

  • May exist in the noninvasive stage for as long as 20 years

  • Shed abnormal cells - detected on cytologic examination

  • Represent a continuum of morphologic change with relatively indistinct boundaries

  • Do not invariably progress to cancer

  • May spontaneously regress

  • Risk of cancer increasing with the severity of the precancerous change

  • Associated with papillomaviruses

  • Papanicolaou smear screening is an effective method in preventing cervical cancer

  • Reason: Majority of cancers preceded by a precancerous lesion

A.Normal exfoliated superficial squamous cervical epithelial cells

B.Papanicolou Smear – CIN I

C.Papanicolou Smear – CIN II

D.Papanicolou Smear – CIN III Note the increase in Nuclear-Cytplasmic Ratio


  • Cervical intraepithelial neoplasia (CIN) classification

  • CIN grade I: Mild dysplasia

  • CIN grade II

  • CIN grade III: Carcinoma in situ

CIN I

  • Extreme low end of the spectrum of morphologic change

  • Lesions indistinguishable histologically from condylomata acuminata

  • Exhibit koilocytotic atypia (viral cytopathic effect) with few alterations in the other cells in the epithelium


  • Viral Cytopathic Effect of HPV in Condyloma

CIN II


  • Appearance of atypical cells in the lower layers of the squamous epithelium

  • Atypical cells show changes characteristics of malignant cells:

  • Change in nucleocytoplasmic ratio

  • Variation in nuclear size (anisokaryosis)

  • Loss of polarity

  • Increased mitotic figures

  • Hyperchromasia

CIN III

  • Progressive loss of differentiation with involvement of more and more layers of the epithelium

  • Until totally replaced by immature atypical cells, exhibiting no surface differentiation


Salient Points of CIN

  • CIN almost always begins at the squamocolumnar junction, in the transformation zone.

  • Lowest grade CIN lesions, including condylomata, mostly do not progress

  • Lesions containing greater degrees of cellular atypia are at greater risk

  • One-third of CIN I and two-thirds of CIN II lesions persist or progress to high grade

  • Not all lesions begin as condylomata or as CIN I

  • May enter at any point in the spectrum, depending on the associated human papillomavirus type and other host factors

  • Lesions that have completely evolved (CIN III) constitute the greatest risk

  • CIN III is most frequently associated with invasive cancer

  • May develop in from a few months to over 20 years.45

Normal Cervical Epithelial Cervical Cancer Transformation Zone



Squamous Cell Carcinoma

  • Squamous cell carcinoma may occur at any age

  • From the second decade of life to senility

  • Peak incidence is occurring at an increasingly younger age:

  • 40 to 45 years for invasive cancer

  • 30 years for high-grade precancers

  • Represents the combination of

  • Earlier onset of sexual activity (i.e., earlier acquisition of human papillomavirus infection)

  • Active Papanicolaou smear screening programs

  • Detecting either cancers or precancerous lesions at an earlier point in life

Squamous Cell Carcinoma Epithelial Pearls


  • Invasive cervical carcinoma manifests in three distinctive patterns:

  • Fungating (or exophytic)

  • Most common variant

  • Produces mass that projects above the surrounding mucosa

  • Ulcerating

  • Infiltrative cancer

  • Advanced cervical carcinoma extends by direct continuity

  • Involve every contiguous structure

  • Peritoneum

  • Urinary bladder

  • Ureters

  • Rectum

  • Vagina

  • Local and distant lymph nodes are also involved

  • Distant metastasis - Liver, lungs, bone marrow, and other structures

Normal Cervix (Nulliparous) Cervical Carcinoma Cervical Carcinoma


  • Histologically:

  • ~95% of squamous carcinomas composed of relatively large cells

  • Keratinizing (well-differentiated)

  • Nonkeratinizing (moderately differentiated)

  • <5% are poorly differentiated small cell squamous

  • More rarely small cell undifferentiated carcinomas (neuroendocrine or oat cell carcinomas)

  • Resemble oat cell carcinomas of lung

  • Unusually poor prognosis owing to early spread by lymphatics and systemic spread

Cervical cancer Staging

  • Stage 0: Carcinoma in situ (CIN III).

  • Stage I: Carcinoma confined to the cervix.

  • Ia: Preclinical carcinoma, i.e., diagnosed only by microscopy but showing:

  • Ia1: Minimal microscopic invasion of stroma (minimally invasive carcinoma) .

  • Ia2: Microscopic invasion of stroma of less than 5 mm in depth (microinvasive carcinoma).

  • Ib: Histologically invasive carcinoma of the cervix that is greater than stage Ia2.

  • Stage II: Carcinoma extends beyond the cervix but not onto the pelvic wall. Carcinoma involves the vagina but not the lower third.

  • Stage III: Carcinoma has extended onto pelvic wall. On rectal examination, there is no cancer-free space between the tumor and the pelvic wall. The tumor involves the lower third of the vagina.

  • Stage IV: Carcinoma has extended beyond the true pelvis or has involved the mucosa of the bladder or rectum. This stage obviously includes those with metastatic dissemination.

Extensive Spread



  • 10-25% of cervical carcinomas constitute adenocarcinomas, adenosquamous carcinomas, undifferentiated carcinomas, or other rare histologic types.

  • Adenocarcinomas tend to have a less favorable prognosis than squamous cell carcinoma of similar stage

  • Clear cell adenocarcinomas of the cervix in DES-exposed women are similar to those occurring in the vagina

Clinical Course – Precancer / Precursors

  • Cancer of the cervix and its precursors evolve slowly over the course of many years

  • During this interval, the only sign of disease may be the shedding of abnormal cells from the cervix

  • Periodic Papanicolaou smears

  • Performed on all women after they become sexually active

  • Detects the possible presence of a cervical precancer or cancer

  • It does not make an absolute diagnosis

  • Colposcopic examination of the cervix

  • CIN lesions are characterized by white patches on the cervix following the application of acetic acid

  • Clinically overt cervical cancers produce

  • Irregular vaginal bleeding

  • Leukorrhea

  • Bleeding

  • Pain on coitus

  • Dysuria

Treatment

  • Depend on the stage of the neoplasm

  • Treatment of precursors

  • Papanicolaou smear follow-up (for mild lesions)

  • Cryotherapy

  • Laser

  • Wire loop excision

  • Cone biopsy

  • Invasive cancers

  • Hysterectomy

  • Radiation for advanced lesions

Prognosis

  • Prognosis and survival for invasive carcinomas depends on the stage at which cancer is first discovered

  • With current methods of treatment, there is a 5-year survival rate:

  • Stage I - 80 to 90%

  • Stage II - 75%

  • Stage III - 35%

  • Stage IV - 10 to 15%

  • Die as a consequence of local extension of the tumor–

  • Into and about the urinary bladder and ureters, leading to ureteral obstruction, pyelonephritis, and uremia–rather than distant metastases


Yüklə 1,15 Mb.

Dostları ilə paylaş:
1   ...   11   12   13   14   15   16   17   18   19




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©genderi.org 2024
rəhbərliyinə müraciət

    Ana səhifə